ZHAO, Yangbing,REN, Jiangtao,LIU, Xiaojun,JUNE, Carl H.
申请号：
HK18102825.7
公开号：
HK1243332A
申请日:
2018.02.27
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
The present invention relates to compositions and methods for generating a modified T cell with a nucleic acid capable of downregulating endogenous gene expression selected from the group consisting of TCR α chain, TCR β chain, beta-2 microglobulin and FAS further comprising a nucleic acid encoding a modified T cell receptor (TCR) comprising affinity for a surface antigen on a target cell or an electroporated nucleic acid encoding a chimeric antigen receptor (CAR). Also included are methods and pharmaceutical compositions comprising the modified T cell for adoptive therapy and treating a condition, such as an autoimmune disease.
